mercredi 9 décembre 2015

Onco Actu du 9 décembre 2015

1. Biologie

Hundreds of researchers are using the wrong cells. That's a major problem. [Retraction Watch]

2. Etiologie

The Naturome Awaits the Nurturome [GEN]

3.1 Tabac

Flavouring found in e-cigarettes linked to 'popcorn lung' [NHS Choices]

Climb down on proposed e-cigarette public place ban [BBC News]

5.2.1 Pharma - Partenariats

Busy Roche inks another immuno-oncology discovery pact, this time with Pieris [FierceBiotech]

Pfizer bets up to $1B on BioAtla's approach to immuno-oncology - FierceBiotech

5.3 Traitements - FDA, EMA,...

Pfizer Announces U.S. FDA Acceptance and Priority Review of Supplemental New Drug Application for XALKORI® (crizotinib) for the Treatment of Patients with ROS1-Positive Metastatic Non-Small Cell Lung Cancer [Pfizer]

Measures to avoid medication errors with Blincyto [EMA]

5.3.4 Traitements - AMM (FDA, EMA)

What chemo patients should know about cap to prevent hair loss [STAT]

FDA allows marketing of cooling cap to reduce hair loss during chemotherapy [FDA]

Teva gets FDA approval for cancer drug [Reuters]

5.5 ASCO

CAP, ASCP, ASCO Invite Public Comment on Gastric Cancer Guideline [ASCO]

5.7.1 SABCS-communiqués

Foundation Medicine Announces Presentations at the 2015 San Antonio Breast Cancer Symposium [Foundation Medicine]

Caris Life Sciences® and Fox Chase Cancer Center – Temple Health Collaborate on Potential New Treatments for Triple-Negative Breast Cancer (TNBC) [Caris Life Sciences]


SABCS 2015: Symposium Co-director Carlos L. Arteaga Previews Important Advances to be Presented [CANCER RESEARCH Catalyst]

A History of the San Antonio Breast Cancer Symposium [CANCER RESEARCH Catalyst]

5.8 ASH

Veni, Vedi, Vene? Venetoclax Hopes to Conquer CLL [The OBR Blog]

At Hematological Meeting, More Than Just Biotech Data Runs Blood Red [Xconomy]

5.8.2 ASH - Pharma

Findings Across a Range of Hematological Cancers Add to The Growing Breadth of KEYTRUDA® (pembrolizumab) Data [Merck]

Phase 3 Results for Zydelig® With Bendamustine and Rituximab for Relapsed Chronic Lymphocytic Leukemia (CLL) Presented at American Society of Hematology Annual Meeting [Gilead]

5.8.4 ASH - CAR T

Killer T-Cells Provide Hope For Treating Toughest Blood Cancers [Forbes]

ASH – CAR-T struggles to travel beyond leukaemia [EP Vantage]

ZIOPHARM Announces Presentation of Data From CD19-Specific CAR+ T-Cell Therapy Programs at ASH Annual Meeting [ZIOPHARM]

5.8.5 ASH - Myélome multiple

Multiple myeloma patient study shows promise for natural killer cells [MD Anderson Cancer Center]

6. Lutte contre les cancers

KI-coordinated EU network establishes cancer partnerships [Karolinska Institutet]

6.1 Observation

Five out of six women at higher risk reject drugs to prevent breast cancer [Cancer Research UK]

6.10 Politiques

Bill creating more orphan drugs would cost consumers billions [STAT]

6.11 Patients

Online symptom monitoring benefits cancer patients [Reuters]

6.7 DMP, Big Data & applis

Watch CancerLinQ LLC CEO Kevin Fitzpatrick’s Presentation During SAP’s Big Data Webinar [ASCO]

6.9 Controverses

Gynecologists call for revision of FDA ruling on device to remove uterine fibroids [Scope Blog]

Doctors dispute FDA’s ruling on uterine surgery technique [Reuters]